Immunotherapy for canine cancer - Is it time to go back to the future?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy for canine cancer - Is it time to go back to the future?

Published:2015-02-23 Issue:4 Volume:56 Page:229-241
ISSN:0022-4510
Container-title:Journal of Small Animal Practice
language:en
Short-container-title:J Small Anim Pract

Author:

Killick D. R.¹,Stell A. J.²,Catchpole B.³

Affiliation:

1. School of Veterinary Science; University of Liverpool; Neston CH64 7TE

2. Department of Clinical Sciences and Services; Royal Veterinary College; Hatfield AL9 7TA

3. Department of Pathology and Pathogen Biology; Royal Veterinary College; Hatfield AL9 7TA

Publisher

Wiley

Subject

Small Animals

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jsap.12336/fullpdf

Reference145 articles.

1. Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model;Akhtar;Neoplasia (New York, NY),2004

2. Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma;Alexander;Cancer immunology, immunotherapy,2005

3. Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicity;Andersen;Cancer Research,2013

4. Mifamurtide for the treatment of nonmetastatic osteosarcoma;Ando;Expert Opinion on Pharmacotherapy,2011

5. Interleukin 2 in cancer therapy;Antony;Current Medicinal Chemistry,2010

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy;Scientific Reports;2022-02-17

2. Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin Lymphoma;Frontiers in Veterinary Science;2021-08-26

3. Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up;Frontiers in Veterinary Science;2021-07-23

4. Intratumoral (Poly-ICLC) Therapy for Dogs with Advanced Cancers: First Report on Clinical Effectiveness, Quality of Life, and Adverse Events;Cancers;2021-05-07

5. A Role for Dogs in Advancing Cancer Immunotherapy Research;Frontiers in Immunology;2020-01-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3